Cellular Engineering Technologies
Innovative biopharmaceutical advancements shaping patient therapy for a healthier future.
Innovative biopharmaceutical advancements shaping patient therapy for a healthier future.
Cellular Engineering Technologies (CET) is a biopharmaceutical company focused on innovative biopharmaceutical advancements that are shaping patient therapy for a healthier future. Founded in 2000 and headquartered in Coralville, Iowa, CET specializes in the fields of biotechnology, pharmaceuticals, and healthcare. In January 2014, the company secured a $30.00K Seed Round investment to further its mission. However, information about the specific investors involved in this round is not available at this time. With its focus on advancing drug discovery, Cellular Engineering Technologies is poised to make significant contributions to the biopharmaceutical industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $30.00K | - | 24 Jan 2014 |
No recent news or press coverage available for Cellular Engineering Technologies.
We care about your data, and we'd love to use cookies make your experience better.
